This text is a result of machine translation.
Anjoy Foods Q3 Net Profit Totaled CNY 386 million, with an Impressive YoY Increase of 63.75%
Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum
A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.
May 18, 2026 02:22 PM
China's Outbound Non-financial Direct Investment Increased 18.8% YoY
Electric Vehicles to Account for Two-thirds of Global Vehicle Sales by 2030
New Energy Vehicle Sales Up 27% in August 2023
Tesla Announces Global Supercharger Network Surpasses 50,000 Units
WeRide Launches Insurance Partnership Program to Support Overseas Expansion
WeRide(文远知行)announced a global insurance partnership program on October 27, naming Allianz Insurance Singapore(安联保险新加坡)and Ping An Property & Casualty Insurance(中国平安财产保险)as its inaugural partners.
Yesterday 11:15 AM
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
GWM Plans Bulgarian Assembly of Ora 5 from Early 2027
Great Wall Motor(长城汽车), known as GWM, announced on October 27 that it plans to begin assembling the Ora 5 compact SUV in Bulgaria in the first quarter of 2027 under an agreement with local partner Bulgarian Automotive Industry.
Oct 28, 2026 05:23 PM
CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM
There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?
Apr 27, 2022 09:45 PM
China biopharmaceutical: the fifth indication of anti-tumor drug "arotinib hydrochloride capsule" has been approved
China biopharmaceutical: second generation highly selective P2X3 inhibitor approved clinical trial
Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%
Capital Has No Passport - In an Age of Economic Sovereignty, how to position “China” in European Capital Markets?
Oct 21, 2026 04:46 PM
Which Way Is the Wind Blowing? How to Balance Geopolitics and Heavy Capex Investment
Oct 08, 2026 05:15 PM